"Kliinilised uuringud erinevate haiguste ära hoidmiseks ja ravi leidmiseks."

During the past decade, Center for Clinical and Basic Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Clinical and Basic Research" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Symic OA Co." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Clinical and Basic Research" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Nordic Bioscience A/S" with 1 trials as a collaborator and "Nordic Bioscience Clinical Development" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Center for Clinical and Basic Research" are "Psoriatic Arthritis" (4 trials), "Osteoarthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Center for Clinical and Basic Research" in a lesser frequency.

Most popular intervention types in "Center for Clinical and Basic Research" are "Drug" (9 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "SB-061" (2 trials), "filgotinib" (2 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "BI 695501" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Clinical and Basic Research" are 12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Clinical and Basic Research". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Center for Clinical and Basic Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Clinical and Basic Research, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".